Collaborations, Competitor News

Graphite Health and Datavant Partner to Bring Privacy-Protected, Secure Exchange to Major Provider Systems

Posted on

Graphite Health member systems to use Datavant Switchboard for secure and privacy-preserving exchange of patient data. SAN FRANCISCO, Sept. 20, 2022 /PRNewswire/ — Graphite Health, a software company intent on transforming the digital future of healthcare, and Datavant, the leader in helping organizations securely connect health data, today announced a collaboration that will enable Graphite Health…

Asia-Pacific, Europe, Government/Regulatory, Industry News, International

Convergence: Global landscape evolves on real-world evidence, but at an uneven pace

Posted on

20 September 2022 | By Mary Ellen Schneider  Left to right: Seema Betigeri, Sabine Haubenreisser, Rob Kalesnik-Orszulak PHOENIX, AZ – Real-world evidence (RWE) is gaining a foothold as an important part of regulatory decision making but health authorities around the world are at different stages of acceptance and policy development. “We…

Industry News

Healthcare data breaches

Posted on

The number of breaches year-to-date is slightly behind 2021 totals but well ahead of previous years. Not a Modern Healthcare subscriber? Sign up today. https://crain-platform-cmh-assets.s3.amazonaws.com/assets/graphics/evergreen/breachtracker-20181022/child.html?initialWidth=634&childId=breachtracker-20181022&parentTitle=Tracking%20healthcare%20data%20breaches%20%7C%20Modern%20Healthcare&parentUrl=https%3A%2F%2Fwww.modernhealthcare.com%2Ftechnology%2Fhealthcare-data-breaches

Competitor News, HR

DNAnexus Appoints Chief Commercial Officer to Accelerate Global Adoption of Leading Biomedical Data-Driven Technology Platform

Posted on

Stephen Nuckols brings more than 25 years of experience leading commercial teams for healthcare and life sciences software companies September 20, 2022 08:05 AM Eastern Daylight Time MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–DNAnexus, Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced the appointment…

Competitor News, RWE Study

Blood Cancer Discovery Publication Further Validates Exscientia’s AI Precision Medicine Platform for Improving Patient Outcomes

Posted on

Findings support deep learning ex vivo drug screening with patient tissue as a promising tool to identify effective, individual treatments in advanced blood cancer over conventional methods Custom deep learning algorithms and single-cell analysis of >1 billion patient cells reveals further potential for improved patient outcomes September 20, 2022 09:00…

AI, Collaborations, Competitor News, Data Partnership, Pharma

CytoReason and Pfizer Extend Collaboration to Leverage Machine Learning in Drug Development

Posted on

TEL AVIV, Israel, Feb. 10, 2022 /PRNewswire/ —CytoReason, a leading developer of computational disease models for efficient drug discovery and development, today announced the extension of its collaboration agreement with Pfizer. “The extension of our collaboration with CytoReason will build upon our existing data science capabilities, and further enhance our ability to…

Collaborations, Competitor News, Data Partnership, International, Japan, RWE Study

Abiomed’s Impella devices show well in Japanese study of cardiogenic shock

Posted on

Abiomed Inc., has worked the ventricular assist device (VAD) space for a number of years with its Impella series of VADs, and a study coming out of Japan seems to affirm investors’ confidence in these devices. This registry study demonstrated that the combination of Impella devices and extracorporeal membrane oxygenation…

Collaborations, Competitor News, Product Updates

Trio Health and Allergy Partners to Form National Allergy and Asthma Patient Registry

Posted on

September 20, 2022 08:00 AM Eastern Daylight Time LOUISVILLE, Colo. & ASHEVILLE, N.C.–(BUSINESS WIRE)–Trio Health (Trio), a leading provider of real-time data on real-world patients, and Allergy Partners, the nation’s largest single speciality practice, today announced a strategic partnership in which Allergy Partners will anchor the formation of a national…

Collaborations, Partner and Collaborator News

Palantir Technologies and Hyundai Heavy Industries Group Grow Partnership to +$45M with Expansion into Shipbuilding

Posted on

September 20, 2022 05:00 PM Eastern Daylight Time DENVER–(BUSINESS WIRE)–Palantir Technologies Inc. (NYSE:PLTR) today announced a major expansion of its partnership with South Korea’s Hyundai Heavy Industries Group by bringing Palantir Foundry to additional companies within the conglomerate. Korea Shipbuilding & Offshore Engineering (KSOE) will utilize the Palantir Foundry operating…